EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy

Naths Grazia Sukubo iD, Paolo Bigini iD, Annalisa Morelli iD

Beilstein Journal of Nanotechnology · 31.01.2025 · 16 · 97-118

DOI: 10.3762/bjnano.16.10 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Beilstein Journal of Nanotechnology, online erschienen am 31.01.2025. Verfasst von Naths Grazia Sukubo und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, Monza, Italy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the coming decades, the development of nanocarriers (NCs) for targeted drug delivery will mark a significant advance in the field of pharmacology. NCs can improve drug solubility, ensure precise distribution, and enable passage across biological barriers. Despite these potential advantages, the interaction with many biological matrices, particularly with existing macrophages, must be considered. In this review, we will explore the dual role of macrophages in NC delivery, highlighting their physiological functions, the challenges posed by the mononuclear phagocyte system, and innovative strategies to exploit macrophage interactions for therapeutic advantage. Recent advancements in treating liver and lung diseases, particularly focusing on macrophage polarization and RNA-based therapies, have highlighted the potential developments in macrophage–NC interaction. Furthermore, we will delve into the intriguing potential of nanomedicine in neurology and traumatology, associated with macrophage interaction, and the exciting possibilities it holds for the future.

Schlagwörter

Stichwörter der Autor:innen

RNA-based therapiesdrug deliverymacrophagesnanomedicinepolarization

Autor:innen und Institutionen

  • School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, Monza, Italy.
  • Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milano, Italy.

ORCID-Profile: Naths Grazia Sukubo, Paolo Bigini, Annalisa Morelli

Förderung

  • NextGenerationEU

Zitieren

APA

Sukubo, N. G., Bigini, P., & Morelli, A. (2025). Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy. Beilstein Journal of Nanotechnology, 16, 97-118. https://doi.org/10.3762/bjnano.16.10

Vancouver

Sukubo NG, Bigini P, Morelli A. Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy. Beilstein Journal of Nanotechnology. 2025;16:97-118. doi:10.3762/bjnano.16.10

BibTeX
@article{Sukubo2025,
  author = {Sukubo, Naths Grazia and Bigini, Paolo and Morelli, Annalisa},
  title = {Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy},
  journal = {Beilstein Journal of Nanotechnology},
  year = {2025},
  volume = {16},
  pages = {97--118},
  doi = {10.3762/bjnano.16.10}
}
Kostenlos starten →